Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2007
09/19/2007EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007EP1190071B1 17867, a novel human aminopeptidase
09/19/2007CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives
09/19/2007CN101039937A Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
09/19/2007CN101039677A Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists
09/19/2007CN101037438A Compositions useful as inhibitors of GSK-3
09/19/2007CN101037429A Extraction method of Chinese medicine of gold buckwheat raw anthocyanin
09/19/2007CN101036782A The application and preparation of anti-inflammatory fused protein for restraining tumor necrosis factor
09/19/2007CN101036773A Application of compound agent in the medicine for treating fracture, tracheitis and depression for human beings
09/19/2007CN101036771A Chinese traditional medicine spray for treating pneumonia and upper respiratory infection
09/19/2007CN101036762A Medicinal composition for treating intractable cough after a cold and its preparing process
09/19/2007CN101036756A Refined yinqiao detoxication dropping pill
09/19/2007CN101036750A Chinese traditional medicine composition took orally for treating repeated hoarseness
09/19/2007CN101036749A External emplastrum for treating asthenic fever for children and the preparing method
09/19/2007CN101036747A Tea for moistening lung and treating cough
09/19/2007CN101036746A Antitussive and antiasthmatic tea
09/19/2007CN101036745A Chinese traditional medicine paste for treating cough and bronchitis for children
09/19/2007CN101036744A A medicine composition, the preparing method and the function
09/19/2007CN101036729A Biological selenium germanium peptide maggot jujube tea powder for preventing SARS
09/19/2007CN101036728A Selenium germanium peptide maggot skin antithrombotic jujube tea powder for curing encephalatrophy radically
09/19/2007CN101036727A Selenium germanium peptide jujube tea powder for preventing avian influenza
09/19/2007CN101036719A Sirup agent for curing cough for children and the preparing method
09/19/2007CN101036710A Oral preparation for treating chough and its preparing process
09/19/2007CN101036694A External emplastrum for curing child demonstration and the method for preparing the same
09/19/2007CN101036686A Method for preparing bitter melon throat cream
09/19/2007CN101036684A Isatis-Root extractive and the purifying method and the medicine combination
09/19/2007CN101036680A Gynura procumbens troche and method for preparing the same
09/19/2007CN101036673A 感冒药 Cold medicine
09/19/2007CN101036651A Naloxone hydrochloride spraying agent for mouth and nose
09/19/2007CN101036533A 健康香烟 Health Cigarette
09/19/2007CN101036492A Chinese holly tea
09/19/2007CN101036491A Expectorant and asthma-curing tea
09/19/2007CN100338089C New method for preparing Ciclesonide medication for treating asthma disease
09/19/2007CN100338086C Immunostimulatory nucleic acid molecules
09/19/2007CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors
09/19/2007CN100337658C Chinese medicine composition for treating cold anemopyretic syndrome, and its preparing method
09/19/2007CN100337655C Medicine preparation for preventing and treating allergic rhinitis and compliance rhinitis
09/19/2007CN100337648C Chinese medicine preparation for treating acute pharyngitis and acute tonsillitis and its preparation method
09/19/2007CN100337645C Medicine composition for treating acute pharyngitis and its prepn
09/19/2007CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/19/2007CN100337614C Medicinal aerosol formulation
09/18/2007USRE39847 Method of treating a systemic disease
09/18/2007US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy
09/18/2007US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action
09/18/2007US7271181 Inhibitors of p38
09/18/2007US7271156 Immunostimulatory nucleic acids
09/18/2007US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors
09/18/2007CA2417106C Piperazine derivatives
09/18/2007CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
09/18/2007CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments
09/18/2007CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
09/18/2007CA2221991C Di- and trivalent small molecule selectin inhibitors
09/18/2007CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
09/18/2007CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
09/18/2007CA2095797C Arylacetamides
09/13/2007WO2007103970A2 Compositions and methods for treating respiratory disorders
09/13/2007WO2007102771A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists
09/13/2007WO2007102769A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
09/13/2007WO2007102768A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
09/13/2007WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
09/13/2007WO2007102515A1 Phenylthiazole derivative
09/13/2007WO2007102011A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
09/13/2007WO2007102008A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
09/13/2007WO2007002972A3 Use of a compound for enhancing the expression of membrane proteins on the cell surface
09/13/2007WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/13/2007US20070213402 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
09/13/2007US20070213401 Pharmaceutical uses for alpha2delta ligands
09/13/2007US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes
09/13/2007US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders
09/13/2007US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
09/13/2007US20070213261 Asthma Preparation
09/13/2007US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
09/13/2007US20070212405 Dispersion for pulmonary delivery of a bioactive agent
09/13/2007DE102006011012A1 Verwendung von Zinkcysteinat zur Behandlung von Entzündungen oder Allergien der Atemwege Using Zinkcysteinat for treating inflammation or respiratory allergies
09/13/2007CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
09/13/2007CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
09/13/2007CA2644613A1 Compositions and methods for treating respiratory disorders
09/13/2007CA2642744A1 Method and composition for treating chronic obstructive pulmonary disease
09/12/2007EP1832599A2 Albumin fusion proteins
09/12/2007EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
09/12/2007EP1832584A1 Pyrimidinylisoxazol derivative
09/12/2007EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine
09/12/2007EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery
09/12/2007EP1832278A1 Zinc cysteinate for treating inflammations or allergies of the respiratory tracts
09/12/2007EP1831367A2 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion
09/12/2007EP1831208A1 Quaternary ammonium salts as m3 antagonists
09/12/2007EP1831202A1 Pyrrolinidium derivatives as m3 muscarinic receptors
09/12/2007EP1831199A1 Novel compounds
09/12/2007EP1831196A1 Novel hydantoin derivatives as metalloproteinase inhibitors
09/12/2007EP1831174A1 Amide derivatives
09/12/2007EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
09/12/2007EP1830881A2 Combining therapies targeting multiple toll-like receptors and use thereof
09/12/2007EP1830875A2 Il-15 antigen arrays and uses thereof
09/12/2007EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
09/12/2007EP1689447A4 Gene transfer for regulating smooth muscle tone
09/12/2007EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/12/2007EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
09/12/2007EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists
09/12/2007EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications